Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 658

1.

Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens.

Hatano R, Yamada T, Madokoro H, Otsuka H, Komiya E, Itoh T, Narita Y, Iwata S, Yamazaki H, Matsuoka S, Dang NH, Ohnuma K, Morimoto C.

PLoS One. 2019 Jun 13;14(6):e0218330. doi: 10.1371/journal.pone.0218330. eCollection 2019.

2.

Intratumoural Immune Cell Landscape in Germinoma Reveals Multipotent Lineages and Exhibits Prognostic Significance.

Takami H, Fukushima S, Aoki K, Satomi K, Narumi K, Hama N, Matsushita Y, Fukuoka K, Yamasaki K, Nakamura T, Mukasa A, Saito N, Suzuki T, Yanagisawa T, Nakamura H, Sugiyama K, Tamura K, Maehara T, Nakada M, Nonaka M, Asai A, Yokogami K, Takeshima H, Iuchi T, Kanemura Y, Kobayashi K, Nagane M, Kurozumi K, Yoshimoto K, Matsuda M, Matsumura A, Hirose Y, Tokuyama T, Kumabe T, Ueki K, Narita Y, Shibui S, Totoki Y, Shibata T, Nakazato Y, Nishikawa R, Matsutani M, Ichimura K; Intracranial Germ Cell Tumor Genome Analysis Consortium (the iGCT Consortium).

Neuropathol Appl Neurobiol. 2019 Jun 10. doi: 10.1111/nan.12570. [Epub ahead of print]

PMID:
31179566
3.

Coefficient of determination between estimated and measured renal function in Japanese patients with sarcopenia may be improved by adjusting for muscle mass and sex: a prospective study.

Nakatani S, Maeda K, Akagi J, Ichigi M, Murakami M, Harada Y, Utsumi S, Fukunaga M, Narita Y, Kondo Y, Ishitsuka Y, Irie T, Kadowaki D, Hirata S.

Biol Pharm Bull. 2019 Jun 4. doi: 10.1248/bpb.b19-00154. [Epub ahead of print]

4.

TAF family proteins and MEF2C are essential for Epstein-Barr virus MYC super-enhancer activity.

Wang C, Jiang S, Zhang L, Li D, Liang J, Narita Y, Hou I, Zhong Q, Gewurz BE, Teng M, Zhao B.

J Virol. 2019 Jun 5. pii: JVI.00513-19. doi: 10.1128/JVI.00513-19. [Epub ahead of print]

PMID:
31167905
5.

Living donor liver transplantation with a left trisection plus caudate lobe graft.

Ibuki S, Abe Y, Shimata K, Narita Y, Irie T, Yamamoto H, Sugawara Y, Hibi T.

Liver Transpl. 2019 Jun 4. doi: 10.1002/lt.25577. [Epub ahead of print]

PMID:
31162780
6.

Single-center Experience of Living-donor Liver Transplantation in Patients Receiving Maintenance Renal Replacement Therapy.

Irie T, Sugawara Y, Narita Y, Ibuki S, Shimata K, Yamamoto H, Hibi T.

Transplant Proc. 2019 Jun;51(5):1520-1521. doi: 10.1016/j.transproceed.2019.01.121.

PMID:
31155186
7.

Understanding of and misunderstandings regarding epilepsy: A survey of teachers in schools for special needs education in Japan.

Narita Y, Hamano SI.

Epilepsy Behav. 2019 May 28;96:160-164. doi: 10.1016/j.yebeh.2019.04.023. [Epub ahead of print]

PMID:
31150994
8.

Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomas.

Nomura M, Saito K, Aihara K, Nagae G, Yamamoto S, Tatsuno K, Ueda H, Fukuda S, Umeda T, Tanaka S, Takayanagi S, Otani R, Nejo T, Hana T, Takahashi S, Kitagawa Y, Omata M, Higuchi F, Nakamura T, Muragaki Y, Narita Y, Nagane M, Nishikawa R, Ueki K, Saito N, Aburatani H, Mukasa A.

Sci Rep. 2019 May 23;9(1):7935. doi: 10.1038/s41598-019-43790-7.

9.

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts.

Takahashi M, Miki S, Fujimoto K, Fukuoka K, Matsushita Y, Maida Y, Yasukawa M, Hayashi M, Shinkyo R, Kikuchi K, Mukasa A, Nishikawa R, Tamura K, Narita Y, Hamada A, Masutomi K, Ichimura K.

Cancer Sci. 2019 May 17. doi: 10.1111/cas.14067. [Epub ahead of print]

10.

Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.

Nejo T, Matsushita H, Karasaki T, Nomura M, Saito K, Tanaka S, Takayanagi S, Hana T, Takahashi S, Kitagawa Y, Koike T, Kobayashi Y, Nagae G, Yamamoto S, Ueda H, Tatsuno K, Narita Y, Nagane M, Ueki K, Nishikawa R, Aburatani H, Mukasa A, Saito N, Kakimi K.

Cancer Immunol Res. 2019 May 14. doi: 10.1158/2326-6066.CIR-18-0599. [Epub ahead of print]

PMID:
31088845
11.

Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.

Wang C, Jiang S, Ke L, Zhang L, Li D, Liang J, Narita Y, Hou I, Chen CH, Wang L, Zhong Q, Ling Y, Lv X, Xiang Y, Guo X, Teng M, Tsao SW, Gewurz BE, Zeng MS, Zhao B.

J Biol Chem. 2019 Jun 21;294(25):9734-9745. doi: 10.1074/jbc.RA119.008793. Epub 2019 May 9.

PMID:
31073033
12.

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer.

Honda K, Gyawali B, Ando M, Kumanishi R, Kato K, Sugiyama K, Mitani S, Masuishi T, Narita Y, Bando H, Taniguchi H, Kadowaki S, Ura T, Muro K.

J Glob Oncol. 2019 May;5:1-8. doi: 10.1200/JGO.19.00003.

13.

RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.

Wang C, Li D, Zhang L, Jiang S, Liang J, Narita Y, Hou I, Zhong Q, Zheng Z, Xiao H, Gewurz BE, Teng M, Zhao B.

J Virol. 2019 Jun 14;93(13). pii: e00226-19. doi: 10.1128/JVI.00226-19. Print 2019 Jul 1.

PMID:
31019051
14.

Portal Vein Stent Placement in Living-donor Liver Transplantation: A Single-center Experience.

Narita Y, Sugawara Y, Ibuki S, Irie T, Shimata K, Yamamoto H, Hibi T.

Transplant Proc. 2019 Jun;51(5):1522-1524. doi: 10.1016/j.transproceed.2019.01.123. Epub 2019 Apr 19.

PMID:
31010697
15.

Living donor liver transplantation for a patient with a history of total gastrectomy.

Shimata K, Irie T, Kadohisa M, Kawabata S, Ibuki S, Narita Y, Yamamoto H, Sugawara Y, Hibi T.

Biosci Trends. 2019 May 12;13(2):212-215. doi: 10.5582/bst.2019.01037. Epub 2019 Apr 15.

16.

Evaluation of the Bactericidal and Fungicidal Activities of Poly([2-(methacryloyloxy)ethyl]trimethyl Ammonium Chloride)(Poly (METAC))-Based Materials.

Shiga T, Mori H, Uemura K, Moriuchi R, Dohra H, Yamawaki-Ogata A, Narita Y, Saito A, Kotsuchibashi Y.

Polymers (Basel). 2018 Aug 26;10(9). pii: E947. doi: 10.3390/polym10090947.

17.

Macrophage-targeted, enzyme-triggered fluorescence switch-on system for detection of embolism-vulnerable atherosclerotic plaques.

Narita Y, Shimizu K, Ikemoto K, Uchino R, Kosugi M, Maess MB, Magata Y, Oku N, Ogawa M.

J Control Release. 2019 May 28;302:105-115. doi: 10.1016/j.jconrel.2019.03.025. Epub 2019 Mar 29.

PMID:
30936020
18.

Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.

Sueyoshi M, Fukunaga M, Mei M, Nakajima A, Tanaka G, Murase T, Narita Y, Hirata S, Kadowaki D.

Clin Exp Nephrol. 2019 Jul;23(7):908-919. doi: 10.1007/s10157-019-01727-4. Epub 2019 Mar 20.

19.

Knowledge and awareness of nonpharmacist salespersons regarding over-the-counter drug use in patients with chronic kidney disease in Japan.

Kondo Y, Ishitsuka Y, Kawabata N, Iwamoto N, Takahashi R, Narita Y, Kadowaki D, Hirata S, Uchino S, Irie T.

PLoS One. 2019 Mar 20;14(3):e0213763. doi: 10.1371/journal.pone.0213763. eCollection 2019.

20.

DNA demethylation is associated with malignant progression of lower-grade gliomas.

Nomura M, Saito K, Aihara K, Nagae G, Yamamoto S, Tatsuno K, Ueda H, Fukuda S, Umeda T, Tanaka S, Takayanagi S, Otani R, Nejo T, Hana T, Takahashi S, Kitagawa Y, Omata M, Higuchi F, Nakamura T, Muragaki Y, Narita Y, Nagane M, Nishikawa R, Ueki K, Saito N, Aburatani H, Mukasa A.

Sci Rep. 2019 Feb 13;9(1):1903. doi: 10.1038/s41598-019-38510-0. Erratum in: Sci Rep. 2019 May 23;9(1):7935.

21.

Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation.

Uto K, Sakamoto S, Que W, Shimata K, Hashimoto S, Sakisaka M, Narita Y, Yoshii D, Zhong L, Komohara Y, Li XK, Inomata Y, Hibi T.

BMC Gastroenterol. 2019 Feb 8;19(1):25. doi: 10.1186/s12876-019-0939-7.

22.

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.

Mitani S, Taniguchi H, Sugiyama K, Masuishi T, Honda K, Narita Y, Kadowaki S, Ura T, Ando M, Tajika M, Yatabe Y, Muro K.

Ther Adv Med Oncol. 2019 Jan 12;11:1758835918820298. doi: 10.1177/1758835918820298. eCollection 2019.

23.

Neurologic Deficit After Aortic Arch Replacement: The Influence of the Aortic Atherosclerosis.

Tokuda Y, Narita Y, Fujimoto K, Mutsuga M, Terazawa S, Ito H, Uchida W, Usui A.

Ann Thorac Surg. 2019 Jan 30. pii: S0003-4975(19)30128-6. doi: 10.1016/j.athoracsur.2019.01.004. [Epub ahead of print]

PMID:
30710519
24.

Publisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Mar;4(3):544. doi: 10.1038/s41564-019-0387-8.

PMID:
30705423
25.

Modified serum creatinine-derived equations with muscle mass-adjusted estimation of renal function and serum cystatin C-derived estimated glomerular filtration rate in elderly individuals
.

Kawakami M, Hirata S, Mizuta M, Hidaka D, Sano H, Isobe K, Nakatani S, Narita Y.

Int J Clin Pharmacol Ther. 2019 May;57(5):229-239. doi: 10.5414/CP203279.

PMID:
30704556
26.

Membrane Fouling Potentials of an Exoelectrogenic Fouling-Causing Bacterium Cultured With Different External Electron Acceptors.

Ishizaki S, Papry RI, Miyake H, Narita Y, Okabe S.

Front Microbiol. 2019 Jan 14;9:3284. doi: 10.3389/fmicb.2018.03284. eCollection 2018.

27.

Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21. Erratum in: Nat Microbiol. 2019 Jan 30;:.

PMID:
30664667
28.

[Successful treatment of post-allogeneic hematopoietic transplant immune thrombocytopenia with eltrombopag].

Narita Y, Uchiyama T, Mizumoto C, Takeoka T, Tomo K, Tsuji M, Ohno T.

Rinsho Ketsueki. 2018;59(11):2418-2422. doi: 10.11406/rinketsu.59.2418. Japanese.

PMID:
30531136
29.

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.

Fukuoka K, Kanemura Y, Shofuda T, Fukushima S, Yamashita S, Narushima D, Kato M, Honda-Kitahara M, Ichikawa H, Kohno T, Sasaki A, Hirato J, Hirose T, Komori T, Satomi K, Yoshida A, Yamasaki K, Nakano Y, Takada A, Nakamura T, Takami H, Matsushita Y, Suzuki T, Nakamura H, Makino K, Sonoda Y, Saito R, Tominaga T, Matsusaka Y, Kobayashi K, Nagane M, Furuta T, Nakada M, Narita Y, Hirose Y, Ohba S, Wada A, Shimizu K, Kurozumi K, Date I, Fukai J, Miyairi Y, Kagawa N, Kawamura A, Yoshida M, Nishida N, Wataya T, Yamaoka M, Tsuyuguchi N, Uda T, Takahashi M, Nakano Y, Akai T, Izumoto S, Nonaka M, Yoshifuji K, Kodama Y, Mano M, Ozawa T, Ramaswamy V, Taylor MD, Ushijima T, Shibui S, Yamasaki M, Arai H, Sakamoto H, Nishikawa R, Ichimura K; Japan Pediatric Molecular Neuro-Oncology Group (JPMNG).

Acta Neuropathol Commun. 2018 Dec 4;6(1):134. doi: 10.1186/s40478-018-0630-1.

30.

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.

Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M.

Neuro Oncol. 2019 Feb 19;21(3):348-359. doi: 10.1093/neuonc/noy200.

PMID:
30500939
31.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):19-33. doi: 10.1093/annonc/mdy502.

PMID:
30475956
32.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Lordick F, Tsushima T, Pentheroudakis G, Baba E, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Kato K, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Nakajima TE, Shitara K, Kawakami H, Narita Y, Yoshino T, Van Cutsem E, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):34-43. doi: 10.1093/annonc/mdy498.

PMID:
30475943
33.

Androgen induced cellular proliferation, neurogenesis, and generation of GnRH3 neurons in the brain of mature female Mozambique tilapia.

Narita Y, Tsutiya A, Nakano Y, Ashitomi M, Sato K, Hosono K, Kaneko T, Chen RD, Lee JR, Tseng YC, Hwang PP, Ohtani-Kaneko R.

Sci Rep. 2018 Nov 15;8(1):16855. doi: 10.1038/s41598-018-35303-9.

34.

Quantitative measurements of hip abduction strength in lumbar surgery patients.

Hatakeyama Y, Miyakoshi N, Senma S, Narita Y, Sasaki K, Sugimura Y, Shimada Y.

J Orthop Sci. 2019 May;24(3):400-403. doi: 10.1016/j.jos.2018.10.018. Epub 2018 Nov 10.

PMID:
30424928
35.

Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.

Itoh T, Hatano R, Komiya E, Otsuka H, Narita Y, Aune TM, Dang NH, Matsuoka S, Naito H, Tominaga M, Takamori K, Morimoto C, Ohnuma K.

J Invest Dermatol. 2019 Apr;139(4):878-889. doi: 10.1016/j.jid.2018.09.037. Epub 2018 Nov 10.

PMID:
30423328
36.

Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases.

Masuishi T, Taniguchi H, Eto T, Komori A, Mitani S, Hasegawa H, Narita Y, Ishihara M, Tanaka T, Kadowaki S, Ura T, Ando M, Tajika M, Nomura M, Sato Y, Mishima H, Muro K.

Anticancer Res. 2018 Nov;38(11):6501-6506. doi: 10.21873/anticanres.13014.

PMID:
30396978
37.

Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604).

Saeki H, Oki E, Kashiwada T, Arigami T, Makiyama A, Iwatsuki M, Narita Y, Satake H, Matsuda Y, Sonoda H, Shimokawa M, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).

Eur J Cancer. 2018 Dec;105:41-49. doi: 10.1016/j.ejca.2018.09.024. Epub 2018 Nov 2.

PMID:
30391779
38.

Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment.

Matsuyama H, Matsuura K, Ishikawa H, Hirata Y, Kato N, Niwa A, Narita Y, Tomimoto H.

Brain Behav. 2018 Dec;8(12):e01143. doi: 10.1002/brb3.1143. Epub 2018 Oct 25.

39.

A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer.

Hashimoto N, Mitani S, Taniguchi H, Narita Y, Kato K, Masuishi T, Kadowaki S, Onishi S, Tajika M, Takahashi S, Shimomura K, Takahata C, Hotta E, Kobara M, Muro K.

Oncologist. 2019 Feb;24(2):159-e66. doi: 10.1634/theoncologist.2018-0580. Epub 2018 Oct 10.

40.

Effect of anatomical change on dose distribution during radiotherapy for maxillary sinus carcinoma: passive scattering proton therapy versus volumetric-modulated arc therapy.

Narita Y, Kato T, Ono T, Oyama S, Komori S, Arai K, Abe Y, Harada T, Nakamura T, Wada H, Kikuchi Y, Murakami M, Hosokawa Y.

Br J Radiol. 2018 Nov 15:20180273. doi: 10.1259/bjr.20180273. [Epub ahead of print]

PMID:
30281327
41.

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer.

Sugiyama K, Narita Y, Mitani S, Honda K, Masuishi T, Taniguchi H, Kadowaki S, Ura T, Ando M, Tajika M, Muro K.

Anticancer Res. 2018 Oct;38(10):5859-5866. doi: 10.21873/anticanres.12928.

PMID:
30275211
42.

Strategy of Cardiovascular Surgery for Patients With Dementia as Evaluated by Mini-Mental State Examination.

Terazawa S, Oshima H, Narita Y, Fujimoto K, Mutsuga M, Tokuda Y, Yoshizumi T, Ito H, Uchida W, Usui A.

Circ J. 2018 Nov 24;82(12):2998-3004. doi: 10.1253/circj.CJ-18-0312. Epub 2018 Sep 27.

43.

Frequent false-negative immunohistochemical staining with IDH1 (R132H)-specific H09 antibody on frozen section control slides: a potential pitfall in glioma diagnosis.

Yoshida A, Satomi K, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Hiraoka N, Narita Y, Ichimura K.

Histopathology. 2019 Jan;74(2):350-354. doi: 10.1111/his.13756. Epub 2018 Dec 5.

PMID:
30221786
44.

<Editors' Choice> Effect of postoperative doxorubicin administration on ischemic wound healing.

Morishita T, Toriyama K, Takanari K, Yagi S, Ebisawa K, Hishida M, Narita Y, Osaga S, Nishida Y, Kamei Y.

Nagoya J Med Sci. 2018 Aug;80(3):357-366. doi: 10.18999/nagjms.80.3.357.

45.

Impact of Surgical Margin in Skull Base Surgery for Head and Neck Sarcomas.

Kobayashi K, Matsumoto F, Miyakita Y, Mori T, Shimoi T, Murakami N, Yoshida A, Arakawa A, Omura G, Fukasawa M, Matsumoto Y, Matsumura S, Itami J, Narita Y, Yoshimoto S.

J Neurol Surg B Skull Base. 2018 Oct;79(5):437-444. doi: 10.1055/s-0037-1615816. Epub 2018 Jan 9.

PMID:
30210970
46.

Site-specific Chemotherapy Based on Predicted Primary Site by Pathological Profile for Carcinoma of Unknown Primary Site.

Hasegawa H, Ando M, Yatabe Y, Mitani S, Honda K, Masuishi T, Narita Y, Taniguchi H, Kadowaki S, Ura T, Muro K.

Clin Oncol (R Coll Radiol). 2018 Oct;30(10):667-673. doi: 10.1016/j.clon.2018.06.012. Epub 2018 Jul 6.

PMID:
30196846
47.

Correction: Por Secretion System-Dependent Secretion and Glycosylation of Porphyromonas gingivalis Hemin-Binding Protein 35.

Shoji M, Sato K, Yukitake H, Kondo Y, Narita Y, Kadowaki T, Naito M, Nakayama K.

PLoS One. 2018 Aug 29;13(8):e0203154. doi: 10.1371/journal.pone.0203154. eCollection 2018.

48.

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas.

Arita H, Kinoshita M, Kawaguchi A, Takahashi M, Narita Y, Terakawa Y, Tsuyuguchi N, Okita Y, Nonaka M, Moriuchi S, Takagaki M, Fujimoto Y, Fukai J, Izumoto S, Ishibashi K, Nakajima Y, Shofuda T, Kanematsu D, Yoshioka E, Kodama Y, Mano M, Mori K, Ichimura K, Kanemura Y.

Sci Rep. 2018 Aug 6;8(1):11773. doi: 10.1038/s41598-018-30273-4.

49.

A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.

Honda K, Gyawali B, Ando M, Sugiyama K, Mitani S, Masuishi T, Narita Y, Taniguchi H, Kadowaki S, Ura T, Muro K.

Ecancermedicalscience. 2018 Jul 5;12:847. doi: 10.3332/ecancer.2018.847. eCollection 2018.

50.

[Phase III Studies on Adult Glioblastoma].

Okita Y, Narita Y.

No Shinkei Geka. 2018 Jul;46(7):561-571. doi: 10.11477/mf.1436203772. Japanese. No abstract available.

PMID:
30049897

Supplemental Content

Loading ...
Support Center